In the past few sessions, Stryker Corporation, medical equipment firm which develops and produces medical implants, surgical and imaging technologies has suffered from a sharp fall and is now coming back on significant level support.
From a fundamental viewpoint, the security is cheap with a PER of 12.7x for 2012 and 11.25x for 2013. Besides, EV/Sales is low with a ratio at 1.91x for this year.
Technically, in daily data, even if moving averages are still in a downtrend, a positive reaction in the USD 49.84 area should stop this trend and allow a technical rebound towards USD 52.70. Moreover, technical indicators show a significant oversold condition which strengthens this bullish scenario.
The trading strategy can benefit from the proximity of the strong support currently tested in order to buy the security in a good timing. Investors might placed a stop loss order at USD 48.3 in order to avoid important losses.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
STRYKER CORPORATION 
